Gyre Therapeutics Inc (GYRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GYRE | AZN | AMGN | GILD | BMY |
| Company | Gyre Therapeutics Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 5.89 | 165.35 | 365.09 | 130.51 | 60.08 |
| High | 6.03 | 166.68 | 367.33 | 131.93 | 60.54 |
| Low | 5.87 | 164.82 | 362.14 | 129.13 | 59.80 |
| Latest | 6.00 | 167.51 | 367.45 | 132.45 | 60.54 |
| Change | +0.12 | +2.99 | +3.28 | -0.76 | +0.38 |
| % Change | +1.96% | +1.82% | +0.90% | -0.57% | +0.63% |
| Volume | 4,774 | 322,900 | 226,614 | 1,139,513 | 655,017 |
| 20-Day Average Volume | 113,529 | 2,637,251 | 2,154,441 | 7,337,484 | 11,699,234 |
| Previous Close | 5.88 | 164.52 | 364.17 | 133.21 | 60.16 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 6.50 | 179.59 | 361.97 | 130.29 | 57.94 |
| 20-Day Raw Stochastic | 5.76% | 7.34% | 62.18% | 40.67% | 74.98% |
| 20-Day Relative Strength | 42.27 | 39.93 | 56.63 | 49.86 | 57.20 |
| Weighted Alpha | -27.97 | +3.21 | +20.29 | +9.21 | +25.77 |
| Today's Opinion | 80% Sell | 88% Sell | 72% Buy | 24% Sell | 56% Buy |
| Previous Opinion | 80% Sell | 88% Sell | 72% Buy | 8% Sell | 56% Buy |
| Last Month's Opinion | 88% Sell | 72% Sell | 8% Sell | 72% Sell | 24% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -6.70% since 07/14/26 | +1.18% since 07/14/26 | +3.04% since 07/14/26 | +0.40% since 07/14/26 | +6.08% since 07/14/26 |
| Low | 5.82 on 07/20/26 | 164.06 on 07/20/26 | 353.95 on 07/15/26 | 129.21 on 07/21/26 | 57.04 on 07/15/26 |
| High | 6.61 on 07/15/26 | 170.37 on 07/16/26 | 378.54 on 07/17/26 | 140.61 on 07/17/26 | 62.29 on 07/17/26 |
| 1-Month | |||||
| %Chg | -5.36% since 06/18/26 | -4.86% since 06/18/26 | +8.42% since 06/18/26 | +5.49% since 06/18/26 | +11.87% since 06/18/26 |
| Low | 5.82 on 07/20/26 | 164.06 on 07/20/26 | 337.60 on 06/22/26 | 123.00 on 06/22/26 | 53.99 on 06/22/26 |
| High | 7.47 on 07/06/26 | 196.41 on 07/02/26 | 378.54 on 07/17/26 | 140.61 on 07/17/26 | 62.29 on 07/17/26 |
| 3-Month | |||||
| %Chg | -24.84% since 04/21/26 | -14.99% since 04/21/26 | +6.14% since 04/21/26 | -2.05% since 04/21/26 | +1.72% since 04/21/26 |
| Low | 5.44 on 06/02/26 | 164.06 on 07/20/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 53.44 on 06/18/26 |
| High | 8.09 on 05/06/26 | 196.65 on 04/22/26 | 378.54 on 07/17/26 | 140.61 on 07/17/26 | 62.29 on 07/17/26 |
| 6-Month | |||||
| %Chg | -28.73% since 01/21/26 | -8.09% since 01/21/26 | +6.53% since 01/21/26 | +1.12% since 01/21/26 | +10.84% since 01/21/26 |
| Low | 5.44 on 06/02/26 | 164.06 on 07/20/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 53.44 on 06/18/26 |
| High | 9.14 on 03/05/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 655,555 | 255,155,376 | 196,545,472 | 165,389,536 | 122,850,992 |
| Shares Outstanding, K | 111,489 | 1,550,908 | 539,708 | 1,241,570 | 2,042,071 |
| Annual Sales | 116,590,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | 5,030,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 22,520,000 | 15,288,000,000 | 8,618,000,000 | 6,960,000,000 | 11,489,000,000 |
| Last Quarter Net Income | -8,690,000 | 3,080,000,000 | 1,819,000,000 | 2,021,000,000 | 2,677,000,000 |
| 60-Month Beta | 1.89 | 0.24 | 0.41 | 0.32 | 0.23 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.05 on 05/07/26 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 1.58 on 04/30/26 |
| Earnings Date | 08/10/26 | 07/27/26 | 08/04/26 | 08/06/26 | 07/30/26 |
| Most Recent Dividend | 0.569 on 08/20/15 | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 06/15/26 | 0.630 on 07/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 06/15/26 | 07/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 201.67 | 18.24 | 16.57 | 16.04 | 10.24 |